Generics Event Diary

Please email info@genericsweb.com to request a conference or exhibition be added to this list.

2013 Archives
2012 Archives
2011 Archives
2010 Archives

2013:

January | February | March | April | May | June | July | August | September | October | November | December

- Click here to view current events -


5th EGA Pharmacovigilance Discussion Forum
16 January, London, UK
: Come and learn directly from the key actors about the new EU pharmacovigilance legislation. Our forum will give you a unique opportunity to ask the right questions and get prepared for the future pharmacovigilance environment.

12th EGA Regulatory and Scientific Affairs Conference
17-18 January, London, UK
: Join the 12th EGA Regulatory and Scientific Affairs Conference to get an update on recent regulatory developments. Representatives from the authorities together with well-known industry experts will present the latest issues and share their point of view on the different topics.

Patent Reform
23-24 January, New York, USA:
For patent attorneys and agents, a reckoning approaches, and yet confusion and misinformation still reign for so many. The generation-defining America Invents Act is going into effect now, and on March 16, 2013, perhaps the biggest provisions of all are set to take hold. Nevertheless, there remain serious questions as to how the USPTO plans to implement aspects of the Act, and what some of their already-issued regulations mean in practice.
Fortunately, American Conference Institute's Comprehensive Guide to Patent Reform will unite an experienced faculty of senior USPTO officials, industry experts, and seasoned practitioners to share best practices.
.

Parallel Trade
6-7 February, London, UK:
SMi are proud to present their 7th annual Parallel Trade conference. Our 2013 agenda will showcase the latest developments in pharmaceutical Parallel Trade, looking at the industry’s rapid expansion and latest arguments from key opinion leaders on this controversial industry. Hear from experts in leading industry sectors; see how big Pharma companies are beginning to combat traders and attempt to prevent counterfeit medicines entering the market. Through case studies see how trading can affect future R&D; pipelines in big pharma drug development. Parallel trade has unique, important legal issues attached to it – hear from specialist pharmaceutical lawyers explaining issues with intellectual property and specific aspects of repackaging. Visit our website here: http://www.smi-online.co.uk/2013paralleltrade17.asp Alternatively Contact Fateja Begum on telephone +44 (0) 20 7827 6184 or email on fbegum@smi-online.co.uk

2013 GPhA Annual Meeting
20-22 February, Orlando, USA:
GPhA’s annual Business Exposition offers a highly interactive and professional business environment in which industry vendors can meet generic industry executives. Building on the success of prior years, we offer our exhibitors abundant networking time with industry decision-makers by hosting breakfasts and breaks in the Expo ballroom. And the Thursday afternoon GPhA Business Expo Reception has proven to be a highly profitable time for our exhibitors.

2013 Generic Congress Europe
26-29 February, London, UK:
GPhA’s annual Business Exposition offers a highly interactive and professional business environment in which industry vendors can meet generic industry executives. Building on the success of prior years, we offer our exhibitors abundant networking time with industry decision-makers by hosting breakfasts and breaks in the Expo ballroom. And the Thursday afternoon GPhA Business Expo Reception has proven to be a highly profitable time for our exhibitors.

PHARM Connect Congress 2013
27-28 February, Budapest, Hungary:
PHARM Connect is the largest pharmaceutical and biotechnology event in Central and Eastern Europe. The congress is bringing together senior decision-makers from Europe’s leading companies, giving them the opportunity to share knowledge and discuss key priorities. The conference programme will include the most up-to-date market insights in R&D;, Production, Packaging, Logistics, and Quality-related topics. The event is also the perfect setting for solution providers to present their products directly to key decision-makers.

euroPLX 51 Limassol
4-5 March, Limassol, Cyprus:
As one of the life science and pharmaceutical industry's most international and most often held partnering events for business deals, euroPLX will be held for the 51st time. At euroPLX 51 Limassol you will only meet pharma and biopharma executives who are in charge of their companies' business development. euroPLX stands for for continuous, productive pharma partnering since 1995. Partnering scope: Registrants determine the "Dynamic Partnering Focus" of this event, displayed on www.europlx.com. It evolves and changes over time within a range from patented to generic (incl. biosimilars), from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices: development, licensing, marketing, promotion, and distribution.

IPI Confex
11-13 March, Seville, Spain:
The IPI-ConfEx is the most significant patent information conference in Europe. For the past 9 years, industry’s thought leaders have gathered together at the IPI-ConfEx for 3 days of knowledge enrichment and exclusive networking opportunities. It the largest gathering of patent information professionals in Europe – it’s the one conference you can’t afford to miss out on in 2013!

EGA legal affairs
19-20 March, Brussels, Belgium:
This session will focus on the recent developments on SPCs:
• Recent developments on SPCs. Session organised in co-operation with GENERICSWEB
• Legal issues that affect the industry
• Update on the unitary patent regulation and the unified patent court
• Review of the paediatrics regulation
• Update on court cases that impact the industry

11th EGA International Symposium on Biosimilar Medicine
25-26 april, London, UK:
Come and meet the EU and international regulators and the leading EU companies in biosimilars. The pre-symposium workshop will explore the mechanics of the Biologics Act with an emphasis on how the Act relates to the involved intellectual property and how the intellectual property may impact the biosimilar applicant’s strategy for entering the market.

Paragraph IV Disputes
7-8 May, New York, USA:
Now in its seventh iteration, American Conference Institute’s (ACI’s) Paragraph IV Disputes conference is the only event which helps both brand name and generic pharmaceutical companies make sense of changing industry dynamics precipitated by the patent cliff and other factors such as patent reform, regulatory shifts and recent and pending case law. This is the conference that not only sets the standards for Paragraph IV litigation, but also serves as the annual meeting place for the “who’s who” of pharmaceutical patent litigation.

BIOtech 2013 in Japan
8-10 May, Big Sight, Tokyo, Japan:
BIOtech 2013 Japan is Asia’s largest bio event, consisting of 3 pillars – Partnering, Conference and Exhibition. Visit here and grab the whole picture of the current and future Asian bio industry.
[Partnering] Interactive networking system involving academics, biotech & pharmaceutical companies.
[Conference] Total 250* presentations by industry leaders and academic presenters
[Exhibition] Asia’s LARGEST with 600* exhibitors
More information & FREE Invitation Ticket Request >>> www.bio-t.jp/en/

Generics and Patent Strategies
13-14 May, The Copthorne Tara Hotel, London, UK:
We are pleased to announce the 16th annual conference, Generics and Patent Strategies, taking place in London from 13-14 May 2013. The conference will see world-renowned experts present the hottest topics and key challenges faced within the Generics industry today in combination with panel discussions that will provide the latest updates on increasing profitability in a highly competitive market.
Register at http://www.smi-online.co.uk/goto/pharma-generics23.asp to secure your place! Alternatively contact Jonathan Collins on +44 0 207 827 6734 or email on jcollins@smi-online.co.uk

Freedom to Operate
15-16 May, The Westin Grand Hotel, Frankfurt, Germany:
C5’s 10th Freedom to Operate Forum brings together eminent in-house counsel from the world’s largest pharma, biotech and chemical companies and their expert advisors from a range of jurisdictions including the US, Europe and Asia. Based on their first-hand experience, the distinguished panel will provide you with invaluable information and insights on FTO.
Plus, add practical value to your experience when you attend the programme’s workshop on: Reading and Analysing Claims in Patents and Patent Applications
To register contact – registratons@c5-online.com or call +44 (0) 20 7878 6888
10% discount code – 552GEN


Pharmaceutical Networking Meeting PharmaVenue

27-28 May, Madrid, Spain: PharmaVenue offers an unparalleled opportunity to identify new business opportunities and meet decision makers to forge new partnerships. PharmaVenue can help your business get to the next level through quality one-to-one meetings with senior level executives. Our state-of-the art interactive partnering software enables you to efficiently select the most attractive license opportunities, pre-arrange and conduct many productive business meetings to unlock future revenue streams in only two days.

Korea Pharm 2013 (Pharmaceutical Ingredient exhibition)

28-31 May, Kintex, Korea: On behalf of Organizer, we cordially invite you to KOREA PHARM 2013 to be held on May 28 ~ 31, 2013, KINTEX, KOREA. Korea’s pharmaceutical Industry is steadily increasing in around 10% every year. KOREA PHARM is the only trade exhibition in Korea specialized in pharmaceutical ingredients.
As KOREA PHARM 2013 is hosted by KFDA (Korea Food & Drug Administration), KOREA PHARM 2013 becomes the most important industrial event of pharmaceutical field in Korea.

Vector Pharma

4-6 June, Mexico City, Mexico: For the second time, Vector Pharma will be the yearly meeting place for manufacturers, distributers and suppliers in the pharmaceutical industry. This event is a forum for business, as well as for discussion, analysis, and revision of the new ideas, policies, regulations, and challenges in the pharmaceutical industry from every country in a completely globalized world. Vector Pharma responds to the pharmaceutical industry commitments set by ANAFAM 68 years ago .In its activities it has strived to promote the development of the established pharmaceutical industry in Mexico, to organize and coordinate events that promote industrial and commercial activity of its members, to associate with other institutions both national and foreign, and to foster the activities and scientific events that will improve and bring the pharmaceutical industry up to date. For all these reasons, Vector Pharma is a nonprofit event.

Pharmaceutical Lifecycle Management Course: Making the Most of Each and Every Brand

5-6 June, Basel, Switzerland: EBCG’s Pharmaceutical Lifecycle Management Course strives to critically assess all of these options, looking at past, concrete examples that have been successful – and those that have been unsuccessful - and evaluating those that will continue to be sustainable going forward. In case you are interested in more information, please visit www.ebcg.biz To receive a special discount (20%), quote GNRW1! .

euroPLX 52 Munich

10-11 June, Munich, Germany: As one of the life science and pharmaceutical industry's most international and most often held partnering events for business deals, euroPLX will be held for the 52nd time. At euroPLX 52 Munich you will only meet pharma and biopharma executives who are in charge of their companies' business development. euroPLX stands for for continuous, productive pharma partnering since 1995.
Partnering scope: Registrants determine the "Dynamic Partnering Focus" of this event, displayed on www.europlx.com. It evolves and changes over time within a range from patented to generic (incl. biosimilars), from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices: development, licensing, marketing, promotion, and distribution.

19th EGA Annual Conference

12-14 June, Athens, Greece: Join your colleagues to gain the latest information on the most important emerging issues facing the generic pharmaceutical industry.
Highlights 2013:
- The European healthcare and pharmaceutical landscape
- Cost containment measures and durable competition in the pharmaceutical market
- Industry facing increasing regulatory burden and pricing pressures
- Is the grass greener in the emerging markets?
- Partnerships for success in the supply chain management
- The world of generic and biosimilar medicines as seen by investors and analysts
- An industrial policy for pharmaceuticals: creating jobs and growth

Generics and Biosimilars

25-26 June, Warsaw, Poland: Hosted by CPhI Conferences, this inaugural, two-day event will highlight opportunities in the region and facilitate in-depth discussion between leading CEE, European and Global generics and biosimilars manufacturers, pharmaceutical and biotech companies, regulators, leading industry experts and key decision makers. Focusing on opportunities and challenges in and outside the region, senior directors, partners and board members will discuss trends in generic and biosimilar development, manufacturing and commercialisation.

Maximising Pharma Patents

25-26 June, Kensington Close Hotel, London, UK: The 12th International Forum on Maximising Pharma Patents will bring together eminent in-house counsel from the world’s largest pharma and biotech companies and their expert advisors from a range of jurisdictions, including the US, Europe and Asia. A special keynote address will be given by leading judge on the unitary patent and the unified patents court.
The forum will include analysis of new procedural rules published by the European Commission on unitary patent and its impact on pharma patent management. Panel speakers will be leading judges, regulatory experts, and industry specialists speaking on how it will work in practice.
To register contact – registratons@c5-online.com or call +44 (0) 20 7878 6888
10% discount code – 580GEN

Parallel Trade Management Strategies

10 July, London, UK: SMi's masterclass hosted by Quintiles is designed to help you address these challenges; provide practical advice and implementable strategies. The masterclass agenda will review the available strategic options including pricing and supply management and will give clear recommendations. Challenges remain for pharmaceutical manufacturers, urging for a robust strategy to face logistic and supply, measuring import and export markets and revenue and profit challenges. Register with the following code to receive £100 off: SMI3P7M

26th INTERPHEX JAPAN – Int’l Pharmaceutical R&D; and Manufacturing Expo/Conference

10-12 July, Big Sight, Tokyo, Japan: INTERPHEX JAPAN is the world's leading pharmaceutical event, covering the whole process of Pharmaceutical R&D; and Manufacturing, from all kinds of equipment to lab devices, contract services, packaging, total solutions and so on. Firmly established as the must-attend event in Japan & Asia, the show has been expanding its scale every year. (1,000 exhibitors and 35,000 visitors are expected at the 2013 show: including concurrent 7th in-PHARMA JAPAN.)
For more information >>> www.interphex.jp/en/

7th in-PHARMA JAPAN – Int’l Pharmaceutical Ingredients Expo & Conference

10-12 July, Big Sight, Tokyo, Japan:The BEST business platform for pharmaceutical ingredients suppliers to expand sales and network in the Japanese pharmaceutical industry. Co-held with the world's leading exhibition for Pharmaceutical R&D; and Manufacturing, in-PHARMA JAPAN is unrivalled in its ability to bring together every key person in the Japanese pharmaceutical market.
Exhibit here and grab your chance in one of the largest and most promising markets, Japan & Asia. >>> www.pijapan.jp/en/

IP and The Generics Industry

17 July, London, UK: SMi’s masterclass hosted by Interpharm will help you to navigate the complicated landscape of intellectual property and generics. IP issues can affect generic development, registration and launch and making mistakes due to a lack of knowledge can work out to be very expensive. Generic companies are increasingly aggressive in their use of patents against each other to gain advantages, which has led to generic wars. Register with the following code to receive £100 off: SMI2Q9P

6th Product and Pipeline Enhancement for Generics Conference

23-25 July, Washington DC, USA: Attendees will be able to identify new ways to do business and better manage the products they have in development with industry leading companies. Stay relevant in the market with razor thin margins and increasing competition for fewer products and the patent cliff. For more information contact Sara Matuszak at 312-540-3000 x6683 saram@marcusevansch.com

GPhA/FDA 2013 ANDA Labeling Workshop/USP User Forum

11-12 September, North Bethesda, USA: Join us for this two-day workshop designed to provide industry with current information on the ANDA labeling review process as well as the many issues now facing the generic industry when submitting ANDA labeling. This workshop will also include a special USP User Forum with a focus on USP topics that relate to labeling. Don’t miss this unique opportunity to hear directly from the FDA’s Office of Generic Drugs (OGD) labeling review staff and Center for Drugs experts as well as USP experts.
Register Today!

Pharma CI Conference

17-18 September, New Jersey, USA: Join us at this premier gathering and network with other key decision makers as you learn about the most pressing and relevant issues facing the competitive intelligence community today. This is the only event featuring a world-class line up of speakers and panelists offering their unique insights and expertise on the topics you care about most! 300+ attendees participated in 2012, and 2013 is expected to be even better!

8th EU Pharma Regulatory Law

18-19 September , London, UK: C5’s EU Pharma Regulatory Law conference taking place on the 18th-19thSeptember 2013 in London, will focus on the practical solutions to the current challenges facing pharma companies, legal practitioners, and regulatory and compliance officers. You will hear the specific strategies used by industry experts in dealing with regulatory challenges in 2013, which will impact your company in 2014 and beyond. Gain insights from the legal opinions of key European and government regulators; hear cutting edge case studies from the lawyers involved; get up-to-date information on the critical issues that will enable your company to maximise profits by avoiding harsh sanctions.
To register contact – registratons@c5-online.com or call +44 (0) 20 7878 6888
10% discount code – 589GEN

The Inaugural Chemspec Asia Exhibition & Conference

18-20 September , Bangkok, Thailand: The leading exhibition and conference in South East Asia for fine and speciality chemicals takes place at BITEC in the vibrant city of Bangkok . The aim is to provide a truly international industry exhibition and a forum to debate and discuss recent developments in the chemical sector, and most importantly, to consider and exploit the commercial opportunities provided by these technological advances.

XI IPLS Meeting

18-20 September , Dublin, Ireland: The 3 day conference programme has been put together by senior industry professionals from across Europe to ensure that the presentations are both topical and varied, with key industry speakers providing their views and opinions. The programme will be split into sections with each section featuring 3 presentations focusing on a particular theme that includes:
- Financing of Deals
- Personalised Medicine
- Mid-Late Stage Licensing
In addition, there will be 6 workshops spread over 2 days on a range of subjects that will offer further insight and debate through interactive sessions

PIUG 2013 Northeast Conference

30 September -2 October, New Brunswick, New Jersey, USA: The PIUG Northeast Conference brings together experts in the area of chemistry/biology, non-chemistry/biology and legal topics relating to patent information. It is an excellent forum to learn and share best practices regarding a specific process in searching and retrieving patent information. Vendors will be available to discuss their expertise and products. The key objective of this five-day meeting is to provide opportunities for learning, networking and professional development.

Biosimilars & Biobetters

1-2 October 2013, Marriott Hotel, Regents Park, London, UK: Building unto the success of last year, Biosimilars & Biobetters 2013 will showcase how biological therapeutics promises to be a radical step forward for many pharmaceutical companies pipelines, looking at how patent expiry dates are playing an important role in why many Pharma companies are pushing for innovative steps to be taken in this field.
The agenda aims to bring together pharma, biotech, CROs with regulatory bodies and legal experts explaining the advantages and disadvantages within this growing market, looking at case studies from those who are developing and distributing follow on biologics with analysis of key trends in biologic pipelines, methods in clinical trials for biosimilar approval, a review of emerging markets, assessment of biosimilar manufacturing, post approval strategy and future forecasting for follow on biologics.

14th Business of Biosimilars

15-17 October, Boston, USA: For 13 years, IIR's Generics and Biosimilar events have delivered crucial and exclusive knowledge about the compliance and commercialization hurdles that you faced on a day-to-day basis. Now more than ever, the insight that we offer can help your company stay on top of the latest regulatory developments while capitalizing on new and untapped markets.
This year's program is designed to provide takeaways for a biosimilar development strategy using a multidisciplinary approach including regulatory strategy, business intelligence, comparability assessment paths, clinical development and more.

CPhI Worldwide

22-24 October, Frankfurt, Germany: CPhI Worldwide - the focal point for the global pharmaceutical industry - is once again in Frankfurt for the 2011 event; a unique and unrivalled gathering for commercial and networking opportunities that enables manufacturers, suppliers, buyers and users to exchange ideas, form alliances and do business on an international scale.
GenericsWeb can be found at stand 63D60.

GPhA/FDA Fall Technical Conference

28-30 October, Bethesda, USA: Come learn and listen to top FDA officials who make up the speaking faculty at this premier generic industry science and regulatory meeting. The Fall Technical Conference now attracts more than 700 industry professionals. Last year the meeting sold out, space is limited, early registration is recommended to secure your spot.
Register Today!

World Biosimilar Congress 2013

12-13 November 2013, Starling Geneva Hotel & Convention Center, Geneva, Switzerland: World Biosimilar Congress 2013 is a proven conference and exhibition bringing together buyers and sellers from across the biosimilar an biobetter industry. The event is Europe’s logical event for Biotech and Pharma players looking to engage in biosimilar drug development and learn from and do business with existing players and new entrants in this growing industry.

World Generic Medicines Congress US

19-21 November, Boston, US: The World Generic Medicines Congress addresses the key market trends, policy updates, strategic overview & future environment for the generics sector. This conference is officially the largest strategic generic conference in the industry and will provide participants with a comprehensive review of business strategy for affordable medicines.

euroPLX 53 Barcelona

25-26 November, Barcelona, Spain: As one of the life science and pharmaceutical industry's most international and most often held partnering events for business deals, euroPLX will be held for the 53rd time, now featuring a new, two-phase partnering system. At euroPLX 53 Barcelona you will only meet pharma and biopharma executives who are in charge of their companies' business development. euroPLX stands for continuous, productive pharma partnering since 1995.
Partnering scope: Registrants determine the "Dynamic Partnering Focus" of this event, displayed on www.europlx.com. It evolves and changes over time within a range from patented to generic (incl. biosimilars), from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices: development, licensing, marketing, promotion, and distribution.

Pharma Networking Meeting

9 December, Barcelona, Spain: PharmaVenue can help your business get to the next level through quality one-to-one meetings with senior level executives. Our state-of-the art interactive partnering software enables you to efficiently select the most attractive license opportunities, pre-arrange and conduct many productive business meetings to unlock future revenue streams.
At our PharmaVenue congress you will be able to meet with CEOs and Senior Executives in Business Development, Licensing, Research as well as Directors of Marketing & Sales.

16th IGPA Annual Conference

9-11 December, Brussels, Belgium: The programme includes speakers representing an unprecedented number of generic medicines associations from the various regions of the world. This event will provide you and your colleagues with the very latest indepth insights into the commercial, legal and regulatory developments of specific concern to the global generic pharmaceutical industry. Informal networking events will offer you ample opportunity to gather up-to-date information while meeting up with old friends and industry colleagues in an instructive yet enjoyable environment.

 

 

 
Contact Us | Terms and Conditions | Privacy Policy | Copyright GenericsWeb 2016